SEC Form 4 · accession 0001077183-19-000013
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond R Hipp
Director
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | M | 10,000 | $4.78 | A | 297,580 | D | |
| Common Stock | Feb 26, 2019 | M | 5,556 | $9.11 | A | 303,136 | D | |
| Common Stock | Feb 26, 2019 | M | 3,333 | $7.27 | A | 306,469 | D | |
| Common Stock | Feb 26, 2019 | S | 18,889 | $18.90 | D | 287,580 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.78 | Feb 26, 2019 | M | 10,000 | D | May 6, 2016 | May 6, 2020 | Common Stock | 10,000 | 0 | D |
| Stock Option (Right to Buy)F2 | $9.11 | Feb 26, 2019 | M | 5,556 | D | Jul 28, 2017 | Jul 28, 2021 | Common Stock | 5,556 | 2,777 | D |
| Stock Option (Right to Buy)F3 | $7.27 | Feb 26, 2019 | M | 3,333 | D | May 25, 2018 | May 25, 2022 | Common Stock | 3,333 | 6,667 | D |
| Stock Option (Right to Buy) | $11.60 | holding | — | — | — | Jun 1, 2019 | Jun 1, 2023 | Common Stock | 3,017 | 3,017 | D |
Explanation of responses
- F1On May 6, 2015, Mr. Hipp was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F2On July 28, 2016, Mr. Hipp was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F3On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.